2.2 Cardiovascular, cardiac Flashcards

(45 cards)

1
Q

Understanding Hypertension

Why the fuss?

A

Why the fuss?
Direct relationship with HTN and CVD
↑ risk of CAD, MI, HF (3x), CVA (4x), renal disease
Elevated SBP greater risk than DBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Understanding Hypertension

What is “high” BP?

A

What is “high” BP?
Persistent SBP ≥ 140 mmHg or DBP ≥ 90 mmHg
Current use of antihypertensives
“Prehypertension” = 120 - 139 SBP or 80 – 89 DBP
2017 guidelines = 130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Understanding Hypertension

What the numbers measure

A

What the numbers measure:
BP is the force exerted by the blood on walls of vessels
SBP= max pressure on walls of the arteries while heart pumping
DBP=minimum pressure between beats while heart is filling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is MAP

A

MAP= average pressure in arterial circulation, calculated value = SBP+2(DBP)/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Isolated systolic HTN

A

Isolated systolic HTN
more common in older adults due to changes in BP patterns
SBP & DBP rises with age until about 55 yr old then DBP begins to decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How the body controls BP
Cardiac output
SVR

A

Its all about perfusion
Systemic and local effects
Cardiac output: How much blood does the heart put out? (volume)

SVR: What is the heart pushing against? (peripheral resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ST and LT mechanisms – usually multiple causes

A

ST and LT mechanisms – usually multiple causes
Sympathetic nervous system :
↑HR, contractility, vasoconstriction, renin release baroreceptors in carotids & aorta communicate w/ brainstem =↑↓BP maintains: normal tone, flow with postural change or exercise

Vascular endothelium: produce vasoactive substances - constrict/dilate

Renal system: controls Na+ excretion and ECF volume, RAAS

Natriuretic peptides: promotes Na and water excretion & vasodilator

Endocrine: adrenal hormones epi and nor epi same as SNS stimulation, pituitary: vasopressin (ADH) raises BP by ↑volume & constriction

ASHD – impacts vessel compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Primary Hypertension (essential)
Without an identified cause;  90 – 95% of all cases
Major contributing factors: subjective & objective data
A
Age
Alcohol
Cigarette smoking
DM, Insulin resistance, Hyperinsulinemia
Elevated serum lipids
Excess dietary Na; low K, Mg, Ca
Gender, family history, ethnicity
Obesity
Sedentary lifestyle
Socioeconomic Status
Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Secondary HTN

A

Secondary Hypertension:
-5 – 10% all cases
-Elevated BP with a specific, identifiable cause
-Suddenly develop high BP, can be severe (crisis)
-Causes: renal disease, cirrhosis, narrowing of aorta, endocrine disorders, meds, neurologic disorders, PIH, sleep apnea, medications
-Clinical findings depend on cause
Unexplained hypokalemia
Abdominal bruit
Variable BP with hx of tachycardia, sweating, & tremor
Renal diseases

Treatment aimed at the underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnostic tests for HTN

A
Urinalysis
CBC
BUN, Creat., Creat clearance, Glomerular filtration rate (GFR)
Electrolytes (K+ for hyperaldosteronism)
Glucose & Hgb A1C (diabetes)
Lipid profile
ECG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Complications (Target Organ Damage)

A

Heart disease
Coronary artery disease (CAD)- atherosclerosis
Left ventricular hypertrophy
Heart failure & dysrhythmia

Cerebrovascular disease
Cerebral atherosclerosis & stroke
Carotid atherosclerosis = TIA and stroke

Peripheral Vascular Disease (PVD)
Speeds up peripheral atherosclerosis → PVD, aortic aneurysm, dissection

Nephrosclerosis (leading cause of ESRD)
Ischemic damage RT ↓lumen of intrarenal blood vessels = tubular atrophy, glomerular destruction, nephron death

Retinal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Collaborative Care for HTN

A

Lifestyle modification
-Reducing overall CV risk & target organ disease
-BP control
Weight reduction: improvements with moderate weight loss
Diet modification
Reduce calories
Reduce sodium (≤2300mg healthy, ≤1500mg if HTN, CKD, DM)
Maintain K and calcium intake
Reduce fat to slow progress of CAD & ↓CVD risk
DASH plan: emphasizes fruits, veggies, low fat dairy, whole grains, fish, beans, seeds, and nuts (box 32-3)
-Moderation of ETOH
-Physical activity - regular exercise
-Avoid tobacco products
-Management of psychosocial risk factors
-Goal BPs (<120/80 if CV risk) guidelines are changing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antihypertensive medications

A

2 main actions: decrease CO or reduce SVR or both
Diuretics: Thiazide, loop diuretics, K+-sparing diuretics
Beta-andrenergic blockers
Centrally acting sympatholytics
Vasodilators
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptors blockers (ARBs)
Calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Understanding CAD(CHD)
Why the fuss?
A

Why the fuss?
CV disease is the leading cause of death in the US
Can lead to MI & contributes to heart failure
Multiple sites of impact: cardiac, peripheral, carotid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Understanding CAD(CHD)

A

What causes it?
Atherosclerosis: deposits lipoproteins & fibrous tissue on arterial wall; RT abnormal lipid metabolism, inflammation & endothelial injury
http://www.webmd.com/heart-disease/video/atherosclerosis

  • Progressive disease
  • Advanced disease by the time its symptomatic
  • ↑Calcification = ↑CAD severity
  • Collateral circulation
  • Framingham study: study of risk since 1949

AKA: CAD, ASHD, ischemic HD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Understanding CAD(CHD)
Major contributing factors: subjective& objective data
A

NONMODIFIABLE risk factors-
Age
Gender
Ethnicity
Family history/Genetic inheritance
MAJOR MODIFIABLE risk factors-
-Elevated serum lipids
Cholesterol ≥200 mg/dl, triglycerides ≥150mg/dl, LDL ≥160mg/dl, or ≤HDL 40 ♂ ( 50♀)
Elevated BP: ≥ 140/90 (≥ 120/80 if DM or CKD)
-Behavioral :Tobacco use, Physical inactivity, Atherogenic diet
-Obesity: waist circumference
-DM – (HTN, obesity)endothelial effects, inflammation, ↑insulin /BS levels
-HTN – damages endothelium & increases atherosclerosis
-Metabolic syndrome
-Emerging risk factors: : ↑homocysteine levels , inflammation (CRP,
♀ risks: early menopause, BCP, HRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Angina

A

Angina: clinical manifestation of cardiac ischemia RT ↑ oxygen demand and/or ↓ oxygen supply. Demand for myocardial oxygen exceeds the ability of coronary arteries to deliver it.
Commonly caused by coronary atherosclerosis that narrows arteries
Inadequate oxygen and glucose to cells in myocardium
Pain is related to anaerobic metabolism & lactic acid buildup
C/O pain, pressure, heavy, squeezing, epigastric burning, can radiate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chronic stable angin

A

Chronic stable angina: intermittent, predictable pain/pressure, relieved when precipitating factor removed, med controlled

“pain” “pressure” “ache” “constrictive” “squeezing” “heavy” rarely sharp or stabbing, “epigastric burning”
Generally substernal, but can radiate to neck, jaw, shoulders, arms, shoulder blades
Pain lasts 5 to 15 min and often goes away when precipitating factor goes away
Rare rest pain
Can schedule meds due to predictable nature of pain
Early am most common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Silent ischemia

A

Silent ischemia: periods of ischemia that occur without sensation of pain or pressure, common in DM, equal prognosis

20
Q

Prinzmetal’s angina

A

Prinzmetal’s angina: at rest, pain RT coronary artery spasm

Pain caused by spasm of coronary artery, not always have CAD. Can occur in pts with Raynaud’s or migraines

21
Q

Unstable angina

A

Unstable angina: emergency, new or worse pain, pain at rest, or with minimal exertion, can indicate impending MI

new or worse, can occur in those with hx of unstable angina or can be the first clinical manifestation of CAD; rapid progression

22
Q

Heart attack, MI

A

Heart attack, MI: caused by prolonged, irreversible ischemia caused by plaque rupture → intima exposure→ platelet aggregation → vasoconstriction & thrombus formation
Ischemia leads to cell death and necrosis = loss of contractile function
Degree of damage depends on
location and size of infarct

23
Q

Heart attack, MI

Assessing angina

A
Assessing angina:
P: precipitating events
Q: quality of pain
R: radiation of pain
S: severity of pain
T: timing
24
Q

Diagnostic tests CAD & angina

A

Labs:
Serum lipids
Cardiac enzymes
Chest xray (CXR)
Cardiac contours, heart size, fluids around heart
Electrocardiogram (EKG)
12 lead; assess the heart’s electrical function/conduction, rhythm, local ischemia or damage, med effectiveness
Telemetry
Stress test (radionuclide testing)
Cardiac catheterization (coronary angiography)

25
Medications for CAD
Goals: ↓oxygen demand and/or ↑oxygen supply - Nitrates- short and long acting - Beta-adrenergic blockers - Calcium Channel Blockers - Angiotensin-converting Enzyme Inhibitors Cholesterol-lowering therapy - Statins - Fibric-acid derivatives - Bile-acid squestrants - Cholesterol Absorption Inhibitors - Complementary lipid lowering agents Antiplatelet agents
26
Understanding heart failure
Heart failure is a chronic, progressive clinical syndrome resulting from any structural or functional disorder that impairs the ability of the to fill with or eject blood. The heart fails to pump blood adequately to meet the body’s metabolic needs. Associated with HTN, CAD, MI High morbidity & mortality rates & frequent hospitalizations
27
Understanding heart failure | Characterized by
Characterized by: - Ventricular dysfunction - Reduced exercise tolerance - Diminished quality of life - Shortened life expectancy
28
Compensatory mechanisms | Sympathetic nervous system
Sympathetic nervous system: heart works faster & harder to ↑CO (↑HR & contractility) Danger: vasoconstricts, ↑myocardial 02 demand, ↑venous return
29
Compensatory mechanisms | Neurohormonal
Neurohormonal: RAAS system, ADH, endothelin, inflammatory Danger: vasoconstriction & Na + H20 retention = ↑blood volume, remodeling (bigger is not better for heart muscle)
30
Compensatory mechanisms | Dilation
Dilation: chambers enlarge RT ↑internal pressure, overstretch Danger: elasticity of cardiac muscle is lost & contraction impaired
31
Compensatory mechanisms | Hypertrophy
Hypertrophy: gradual ↑heart muscle mass Danger: contractility, O2 demands, poor circulatory supply, prone to dysrhythmias
32
Causes of HF | PRIMARY
``` PRIMARY: CAD, MI HTN Rheumatic heart disease Congenital defects Pulmonary hypertension Cardiomyopathy Hyperthyroidism Valve disorders Myocarditis ```
33
Causes of HF | PRECIPITATING
``` PRECIPITATING: acute (often ↑ workload) Anemia- decreased 02 capacity of blood causes increased CO to compensate Infection Hypothyroid- predisposes to CAD Dysrhythmias Bacterial endocarditis Pulmonary disease Nutritional deficiencies Hypervolemia ```
34
Classifying Types of Heart Failure
Acute vs chronic Systolic vs diastolic (pumping vs filling problem) Left ventricular vs right ventricular
35
Acute HF
``` Pulmonary edema Lung alveoli filled with ISF Interstitial edema RT ↑ intravascular pressure S/S: tachypnea ≥30 RR; anxious; pale, clammy, & cold skin; dyspnea, respiratory distress; frothy blood-tinged sputum, rales/rhonchi/wheeze Often fluid overload ```
36
Chronic HF
``` S/S depend on pt age & extent of underlying CV disease FACES F- fatigue A- activity limitation C- cough/chest congestion E- edema S- SOB See page 1060 for multisystem effects of HF (acute & chronic) ```
37
Systolic failure
Systolic failure: decreased pumping function Caused by: Damage to cardiac muscle: ischemia/infarct, inflammation (cardiomyopathy) Increased afterload (force the heart works against) eg: HTN, CAD abnormalities eg valve dysfunction Ventricle doesn’t generate enough pressure to eject blood forward Ejection fraction (EF) is decreased, S/S RT ↓output
38
Diastolic failur
Diastolic failure: inability of ventricles to relax & fill; Caused by stiff ventricles →High filling pressures that cause venous engorgement in pulmonary & peripheral vessels S/S RT congestion behind ventricle & ↑pressure Dx.- pulmonary congestion, pulmonary HTN, ventricular hypertrophy with a normal EF
39
LEFT VS RIGHT FAILURE
More useful concept in acute failure, chronic often both ``` LEFT HF Causes: CAD, HTN S/S pulmonary congestion (SOB, cough, orthopnea, crackles, murmur) ↓output (fatigue, dizziness, syncope) ``` RIGHT HF Causes: pulmonary disease, LHF S/S RT venous pressure in systemic circulation= edema, ascites, JVD
40
S/S HF
Fatigue-earliest symptom due to decreased cardiac output Dyspnea-caused by interstitial and alveolar edema, PND. Orthopnea-how many pillows for sleep? Tachycardia-Early sign of HF. Compensation for failing ventricular function. Edema- dependent, liver, ascites, lungs, grade pitting Nocturia-6-7 times per night (increased renal blood flow) Skin changes-dusky, cool and damp Behavioral changes-cerebral circulation impaired Chest pain-decreased coronary perfusion Weight changes-fluid retention (3 lbs in 2 days)
41
Diagnostic tests for HF
``` ABGs if acute distress B-type Natriuretic Peptide (BNP) Liver function tests Chest x-ray 12-lead EKG Nuclear imaging studies: Thallium scan Echocardiography Exercise Stress test Cardiac catheterization ```
42
B-type Natriuretic Peptide (BNP)
Protective mechanism Released by the myocytes of the ventricles in response to excess stretch created by volume overload Work by: SHIFT FLUID TO EXTRAVASCULAR COMPARTMENT BY INCREASING PERMEABILTY ACT ON KIDNEY = diuresis (loss of water) & natriuresis (loss of Na) DILATE ARTERIOLES & VEINS PREVENT PROLIFERATION OF MYOCYTES IN EARLY HF BNP levels correlate with the degree of left ventricular dysfunction Very useful in differentiating cardiac and respiratory causes of dyspnea
43
Echocardiogram
Several types of echos (TTE 2D, 3D, duplex, stress, TEE) Sometimes combined with dopplers to measure flow All are ultrasounds – use sound waves to evaluate the structure and function of the heart (heart size, wall motion, valve abnormalities, vegetation) Patient education video: http://www.youtube.com/watch?v=0eKdhHF-JLg
44
Medications for HF
``` Diuretics – for volume excess RAAS inhibitors – ↓workload, remodeling, Aldosterone ACE /ARB * Aldosterone antagonists –reduce remodeling/fibrosis Direct renin inhibitors Vasodilators Beta adrenergic blockers Neprilysin inhibitors – Entresto (sacubitril/valsartan) Positive inotropes - digoxin Antidysrhythmics Anticoagulants if afib *guideline-directed medical therapy ```
45
Patient/Family Teaching
Daily weights: notify Dr, if gain of 2-4 lbs in 1-3 days or 3-5 lbs in a week. Symptoms of SOB, swelling and fatigue Report S/S exacerbation; Edema, swelling, SOB, or fatigue Weight management Sodium-restricted low fat diet Activity plan Medication Education